U.S. News & World Report releases hospital rankings

The annual ranking of U.S. hospitals by the news magazine U.S. News & World Report has long stirred controversy, particularly by the heavy weight it gives to hospital reputation as measured by the votes of just a few hundred American Medical Association member physicians. However, its influence in hospital marketing is undeniable.

Cracking the top spot for the first time this year was the Mayo Clinic, followed by similar name-brand institutions.

1

Mayo Clinic, Rochester, Minnesota

2

Massachusetts General Hospital, Boston

3

Johns Hopkins Hospital, Baltimore

4

Cleveland Clinic

5

UCLA Medical Center, Los Angeles

6

New York-Presbyterian University Hospital of Columbia and Cornell, New York

7

Hospitals of the University of Pennsylvania-Penn Presbyterian, Philadelphia

8

UCSF Medical Center, San Francisco

9

Brigham and Women's Hospital, Boston

10

Northwestern Memorial Hospital, Chicago

11

University of Washington Medical Center, Seattle

12 (tie)

Cedars-Sinai Medical Center, Los Angeles

12 (tie)

UPMC-University of Pittsburgh Medical Center

14

Duke University Hospital, Durham, North Carolina

15

NYU Langone Medical Center, New York

16

Mount Sinai Hospital, New York

17

Barnes-Jewish Hospital/Washington University, St. Louis

Roughly a third of a hospital’s rank is based on reputation, and as Michael Holers, M.D., head of the University of Colorado School of Medicine’s Division of Rheumatology, noted in a University publication last year, voters, like him, generally just put down the names of the institutions that first spring to mind, not necessarily the ones they know a great deal about personally.

“The program that comes most readily to mind, based on a long history or a recent mailing, is what you put down,” he said.

The American Hospital Association has pushed back against some of the influence of ratings. In 2012, it took Leapfrog Group to task for how it measured hospital safety in its annual report card rankings.

The Centers for Medicare and Medicaid Services’ efforts to make its quality and outcome data more accessible to beneficiaries is another possible way to reduce the influence of consumer-oriented lists like U.S. World News and Reports. However, until government data becomes a lot more accessible and easy to use, it is unlikely to pose much challenge to the influence of the popular U.S. World News and Reports annual rankings.

Lena Kauffman,

Contributor

Lena Kauffman is a contributing writer based in Ann Arbor, Michigan.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.